Desktop Metal Qualifies Sterling Silver on the Production System, Cementing Additive Manufacturing Leadership in Jewelry Industry
7.6.2022 11:01:00 EEST | Business Wire | Press release
Desktop Metal (NYSE: DM) today announced that 925 sterling silver, a popular precious metal, is now qualified for 3D printing on the Production System™ platform, including both the P-1 and P-50, offering jewelry and luxury goods manufacturers the fastest way to directly 3D print high-quality jewelry, watches, belt buckles, and decorative hardware for handbags.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220606005677/en/
Exquisite sterling silver chevron stacking rings designed by Christian Tse and 3D printed on the Desktop Metal Production System P-1. The Production System now offers jewelry and luxury goods manufacturers the fastest way to directly 3D print high-quality sterling silver jewelry, watches, belt buckles, and decorative hardware for handbags. (Photo: Business Wire)
Desktop Metal is also fast-tracking the development of additional precious metal alloys in 2022, including 18K yellow gold, with active research and development underway on rose gold. Desktop Metal and its ETEC polymer brand have a longtime history of partnering with major jewelry producers around the world such as Cartier, Stuller, Shinola and Swarovski.
“The qualification of precious metals for direct 3D printing on high-speed binder jetting systems is a major milestone for the jewelry and luxury goods industry,” said Ric Fulop, Founder and CEO of Desktop Metal. “All the design freedom and customization of 3D printing can now be delivered directly at high volumes without all of the labor associated with traditional manufacturing processes. What’s more, this new direct 3D printing innovation builds on the established legacy of our ETEC brand, which has been a leader in 3D printers for lost-wax casting models for more than a decade — making us the unparalleled leader in comprehensive additive manufacturing solutions for the jewelry and luxury goods market.”
Partnerships to Advance Technology and Materials Development
To advance the technology and materials needed to bring world-class 3D printing quality, productivity, and economics to the demanding luxury goods and jewelry market, Desktop Metal is partnering with two leaders in precious metals powder and parts production: Formula 3D Corporation founded by Christian Tse of Christian Tse Designs & Manufacturing Inc. for the U.S. market, and Neoshapes for international clientele. Both of these collaborations aim to enable the luxury goods and jewelry markets to adopt metal binder jetting processes to produce end-use parts in precious metals, steels, and more.
Formula 3D Corporation offers designers and manufacturers a complete end-to-end solution for 3D printing precious metals — from the design to beautiful, customer-ready finished quality jewelry. A new video released with Christian Tse showcases how this Monrovia, California-based luxury design and manufacturing house is using the Desktop Metal Production System P-1 to reimagine its jewelry manufacturing.
“Desktop Metal’s Production System adds extraordinary value to our existing jewelry manufacturing processes, increasing efficiency of production, getting new designs to market faster, and offering our customers greater versatility and multiple styling options. We can actually print in precious metals in two hours what we do in two days with casting,” said Christian Tse. “In addition, creating jewelry with binder jetting is allowing us to consider new options to circumvent some of the supply chain challenges facing the fine jewelry industry. We can bypass shipping delays and mounting costs, as well as avoid duties, by printing the precious silver directly, as opposed to shipping the physical metal.”
Neoshapes, a Swiss company based in Geneva, Switzerland, founded by experienced executives in the luxury goods industry, takes a unique end-to-end approach — from the production and supply of powder, to the printing and post-processing of precious metals components, as well as consultancy services to enable industry players to easily transition their production processes to binder jet technology.
“Binder jetting opens up new perspectives for the luxury industry, even more now with the qualification of precious metal alloys, giving further leverage to develop and produce creative products from a single file, leaping forward into the digital supply chain. The time to market for new creative products is also reduced considerably, allowing brands to better meet demand while maintaining minimal inventories,” said Stéphane Vigié, Neoshapes co-founder.
Binder Jetting Ushers in a New Era for Jewelry Manufacturing
The Production System’s Single Pass Jetting™ (SPJ) technology, which delivers high-speed 3D printing of metals, enables jewelers to adopt an entirely digital and agile manufacturing workflow. Jewelers can have greater design flexibility and control, allowing designers and manufacturers to scale new designs previously impossible or difficult to produce without significant manual labor — such as chain link bracelets or necklaces, where the links can be 3D printed in place as one piece instead of being manually assembled one link at a time. In addition, jewelers can leverage AM for localized production, decreasing the reliance on long lead-time global supply chains and offering opportunities for onshoring manufacturing.
The benefits of additive manufacturing for luxury goods and jewelry applications are significant:
- Customization and Design Freedom at High Volumes
Up to tens of thousands of jewelry pieces per day can be 3D printed on the Production System, and manufacturers can produce the same pieces or customized, unique ones — all in a single build.
- Digital Inventory Offers Greater Production Flexibility
By eliminating time-intensive techniques like casting, manufacturers can iterate and scale new designs easily — once a design is finalized, printing and production can begin immediately. Manufacturers can also establish digital inventories, storing design files digitally to be made on demand, reducing working capital requirements.
- Significant Reduction in Waste Material through Recycling and Reuse
With the Production System, substantially all of the loose powder recovered during the printing and depowdering process can be recycled and reused for subsequent prints, driving further cost efficiencies and reducing material waste.
World’s Fastest Way to 3D Print Sterling Silver Jewelry on Display at JCK Show
Exquisite jewelry designs from Christian Tse printed in sterling silver on the Production System will be on display June 10-13 in Las Vegas at the 2022 JCK Show, a leading jewelry event in North America, at stand #52025. In addition, Desktop Metal will exhibit affordable solutions for jewelry casting, including the ETEC D4K printer, a high-resolution professional-grade desktop 3D printer, suitable for end-use applications, dental, and jewelry.
To learn more about the Production System and printing in precious metals, visit: www.desktopmetal.com/production.
About Desktop Metal
Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with an expansive portfolio of 3D printing solutions, from rapid prototyping to mass production. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make additive manufacturing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum, named to MIT Technology Review’s list of 50 Smartest Companies, and the 2021 winner of Fast Company’s Innovation by Design Award in materials and Fast Company’s Next Big Things in Tech Award for sustainability. For more information, visit www.desktopmetal.com.
About Formula 3D Corporation
Founded in 2019 by Christian Tse, Formula 3D Corporation is an additive manufacturing company focused on precious metals, supplying 3D printing products and solutions for the fine jewelry, dental, medical, and space travel industries. Based in Monrovia, CA, Formula 3D aims to revolutionize the US manufacturing industry by providing access to a full ecosystem of 3D precious metal manufacturing services and products, including atomized powders, 3D printing, touchless finishing, and metal alloys. www.formula3Dcorp.com.
About Neoshapes®
With extensive experience in Additive Manufacturing to serve the luxury industry, Neoshapes is the first integrated specialist dedicated to 3D printing for the global luxury goods sector. With a strong focus on precious metals, Neoshapes proposes a full range of turnkey solutions that ensure increased efficiency and superior quality excellence for its Partner Brands. Neoshapes was established to respond to the ever-evolving needs of the luxury industry, specifically a more personalized connection to consumers with services such as production-on-demand, limited editions, customization, and special orders – growing trends that currently are not well served by traditional manufacturing methods. Based in Geneva, Switzerland, Neoshapes is fully committed to luxury goods 3D printing with core competencies in precious metals, from traceability of materials, through to alloying, powdering, printing, finishing, and traceability of finished products, all under one roof.
Forward-looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to, the risks and uncertainties set forth in Desktop Metal, Inc.'s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005677/en/
Contact information
Media Relations:
Desktop Metal Contact
Lynda McKinney
lyndamckinney@desktopmetal.com
(978) 224-1282
Christian Tse Contact
Duvall O’Steen
duvall@luxbrandgroup.com
(917) 363-3724
Neoshapes Contact
Gautier Mougel
gautier.mougel@Neoshapes.com
+41 76 817 85 45
Investor Relations:
Jay Gentzkow
jaygentzkow@desktopmetal.com
(781) 730-2110
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 09:00:00 EET | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greatest difference between treatment groups was observed at Week 6 (adjusted mean difference, −1.14 points; p=0.0488).
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
